aluates Reports

$ 0.0

Automative

Global Recombinant Human M-CSF Protein Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-28W18836

BUY CHAPTERS

Global Recombinant Human M-CSF Protein Market Research Report 2025

Code: QYRE-Auto-28W18836

Report

March 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Regulator

Novartis

Amgen Inc

Betta Pharmaceuticals

Thermo Fisher Scientific Inc

Eli Lilly and Company

Bio-Techne

Merck

Yeasen

Sino Biological

Miltenyi Biotec

Proteintech

BioLegend

Recombinant Human M-CSF Protein Market Size

The global market for Recombinant Human M-CSF Protein was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 269 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Recombinant Human M-CSF Protein Market

Macrophage colony stimulating factor (M-CSF) is a potent hematopoietic factor produced by a variety of cells, including lymphocytes, monocytes, fibroblasts, endothelial cells, myoblasts, and osteoblasts. It is a key regulator of proliferation, differentiation, and survival of blood monocytes, tissue macrophages, and their respective progenitors. M-CSF has been shown to play an important role in regulating skin thickness and fertility. M-CSF is used clinically to treat infections, malignancies, and atherosclerosis. It helps hematopoietic recovery after bone marrow transplantation.

North American market for Recombinant Human M-CSF Protein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Human M-CSF Protein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Recombinant Human M-CSF Protein in Medical and Biological Laboratories is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Recombinant Human M-CSF Protein include Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, Bio-Techne, Merck, Yeasen, Sino Biological, Miltenyi Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Recombinant Human M-CSF Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human M-CSF Protein.

The Recombinant Human M-CSF Protein market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human M-CSF Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human M-CSF Protein companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Recombinant Human M-CSF Protein Market Report

Report Metric	Details
Report Name	Recombinant Human M-CSF Protein Market
Accounted market size in year	US$ 157 million
Forecasted market size in 2031	US$ 269 million
CAGR	8.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Purity＞95% Purity≤95%
Segment by Application	Medical and Biological Laboratories University Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, Bio-Techne, Merck, Yeasen, Sino Biological, Miltenyi Biotec, Proteintech, BioLegend
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human M-CSF Protein company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Human M-CSF Protein Market growing?

Ans: The Recombinant Human M-CSF Protein Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Recombinant Human M-CSF Protein Market size in 2031?

Ans: The Recombinant Human M-CSF Protein Market size in 2031 will be US$ 269 million.

Who are the main players in the Recombinant Human M-CSF Protein Market report?

Ans: The main players in the Recombinant Human M-CSF Protein Market are Novartis, Amgen, Betta Pharmaceuticals, Thermo Fisher Scientific Inc., Eli Lilly and Company, Bio-Techne, Merck, Yeasen, Sino Biological, Miltenyi Biotec, Proteintech, BioLegend

What are the Application segmentation covered in the Recombinant Human M-CSF Protein Market report?

Ans: The Applications covered in the Recombinant Human M-CSF Protein Market report are Medical and Biological Laboratories, University Laboratories, Others

What are the Type segmentation covered in the Recombinant Human M-CSF Protein Market report?

Ans: The Types covered in the Recombinant Human M-CSF Protein Market report are Purity＞95%, Purity≤95%

Recommended Reports

Recombinant Proteins

Cell and Gene Therapy

Growth Factors

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Recombinant Human M-CSF Protein Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Purity＞95%

1.2.3 Purity≤95%

1.3 Market by Application

1.3.1 Global Recombinant Human M-CSF Protein Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Medical and Biological Laboratories

1.3.3 University Laboratories

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Recombinant Human M-CSF Protein Market Perspective (2020-2031)

2.2 Global Recombinant Human M-CSF Protein Growth Trends by Region

2.2.1 Global Recombinant Human M-CSF Protein Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Recombinant Human M-CSF Protein Historic Market Size by Region (2020-2025)

2.2.3 Recombinant Human M-CSF Protein Forecasted Market Size by Region (2026-2031)

2.3 Recombinant Human M-CSF Protein Market Dynamics

2.3.1 Recombinant Human M-CSF Protein Industry Trends

2.3.2 Recombinant Human M-CSF Protein Market Drivers

2.3.3 Recombinant Human M-CSF Protein Market Challenges

2.3.4 Recombinant Human M-CSF Protein Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Recombinant Human M-CSF Protein Players by Revenue

3.1.1 Global Top Recombinant Human M-CSF Protein Players by Revenue (2020-2025)

3.1.2 Global Recombinant Human M-CSF Protein Revenue Market Share by Players (2020-2025)

3.2 Global Top Recombinant Human M-CSF Protein Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Recombinant Human M-CSF Protein Revenue

3.4 Global Recombinant Human M-CSF Protein Market Concentration Ratio

3.4.1 Global Recombinant Human M-CSF Protein Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human M-CSF Protein Revenue in 2024

3.5 Global Key Players of Recombinant Human M-CSF Protein Head office and Area Served

3.6 Global Key Players of Recombinant Human M-CSF Protein, Product and Application

3.7 Global Key Players of Recombinant Human M-CSF Protein, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Human M-CSF Protein Breakdown Data by Type

4.1 Global Recombinant Human M-CSF Protein Historic Market Size by Type (2020-2025)

4.2 Global Recombinant Human M-CSF Protein Forecasted Market Size by Type (2026-2031)

5 Recombinant Human M-CSF Protein Breakdown Data by Application

5.1 Global Recombinant Human M-CSF Protein Historic Market Size by Application (2020-2025)

5.2 Global Recombinant Human M-CSF Protein Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Recombinant Human M-CSF Protein Market Size (2020-2031)

6.2 North America Recombinant Human M-CSF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Recombinant Human M-CSF Protein Market Size by Country (2020-2025)

6.4 North America Recombinant Human M-CSF Protein Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Recombinant Human M-CSF Protein Market Size (2020-2031)

7.2 Europe Recombinant Human M-CSF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Recombinant Human M-CSF Protein Market Size by Country (2020-2025)

7.4 Europe Recombinant Human M-CSF Protein Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Recombinant Human M-CSF Protein Market Size (2020-2031)

8.2 Asia-Pacific Recombinant Human M-CSF Protein Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Recombinant Human M-CSF Protein Market Size by Region (2020-2025)

8.4 Asia-Pacific Recombinant Human M-CSF Protein Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Recombinant Human M-CSF Protein Market Size (2020-2031)

9.2 Latin America Recombinant Human M-CSF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Recombinant Human M-CSF Protein Market Size by Country (2020-2025)

9.4 Latin America Recombinant Human M-CSF Protein Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Recombinant Human M-CSF Protein Market Size (2020-2031)

10.2 Middle East & Africa Recombinant Human M-CSF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Recombinant Human M-CSF Protein Market Size by Country (2020-2025)

10.4 Middle East & Africa Recombinant Human M-CSF Protein Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Recombinant Human M-CSF Protein Introduction

11.1.4 Novartis Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Recombinant Human M-CSF Protein Introduction

11.2.4 Amgen Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 Betta Pharmaceuticals

11.3.1 Betta Pharmaceuticals Company Details

11.3.2 Betta Pharmaceuticals Business Overview

11.3.3 Betta Pharmaceuticals Recombinant Human M-CSF Protein Introduction

11.3.4 Betta Pharmaceuticals Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.3.5 Betta Pharmaceuticals Recent Development

11.4 Thermo Fisher Scientific Inc.

11.4.1 Thermo Fisher Scientific Inc. Company Details

11.4.2 Thermo Fisher Scientific Inc. Business Overview

11.4.3 Thermo Fisher Scientific Inc. Recombinant Human M-CSF Protein Introduction

11.4.4 Thermo Fisher Scientific Inc. Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.4.5 Thermo Fisher Scientific Inc. Recent Development

11.5 Eli Lilly and Company

11.5.1 Eli Lilly and Company Company Details

11.5.2 Eli Lilly and Company Business Overview

11.5.3 Eli Lilly and Company Recombinant Human M-CSF Protein Introduction

11.5.4 Eli Lilly and Company Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.5.5 Eli Lilly and Company Recent Development

11.6 Bio-Techne

11.6.1 Bio-Techne Company Details

11.6.2 Bio-Techne Business Overview

11.6.3 Bio-Techne Recombinant Human M-CSF Protein Introduction

11.6.4 Bio-Techne Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.6.5 Bio-Techne Recent Development

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Recombinant Human M-CSF Protein Introduction

11.7.4 Merck Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.7.5 Merck Recent Development

11.8 Yeasen

11.8.1 Yeasen Company Details

11.8.2 Yeasen Business Overview

11.8.3 Yeasen Recombinant Human M-CSF Protein Introduction

11.8.4 Yeasen Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.8.5 Yeasen Recent Development

11.9 Sino Biological

11.9.1 Sino Biological Company Details

11.9.2 Sino Biological Business Overview

11.9.3 Sino Biological Recombinant Human M-CSF Protein Introduction

11.9.4 Sino Biological Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.9.5 Sino Biological Recent Development

11.10 Miltenyi Biotec

11.10.1 Miltenyi Biotec Company Details

11.10.2 Miltenyi Biotec Business Overview

11.10.3 Miltenyi Biotec Recombinant Human M-CSF Protein Introduction

11.10.4 Miltenyi Biotec Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.10.5 Miltenyi Biotec Recent Development

11.11 Proteintech

11.11.1 Proteintech Company Details

11.11.2 Proteintech Business Overview

11.11.3 Proteintech Recombinant Human M-CSF Protein Introduction

11.11.4 Proteintech Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.11.5 Proteintech Recent Development

11.12 BioLegend

11.12.1 BioLegend Company Details

11.12.2 BioLegend Business Overview

11.12.3 BioLegend Recombinant Human M-CSF Protein Introduction

11.12.4 BioLegend Revenue in Recombinant Human M-CSF Protein Business (2020-2025)

11.12.5 BioLegend Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Regulator

Novartis

Amgen Inc

Betta Pharmaceuticals

Thermo Fisher Scientific Inc

Eli Lilly and Company

Bio-Techne

Merck

Yeasen

Sino Biological

Miltenyi Biotec

Proteintech

BioLegend

List of Tables

Table 1. Global Recombinant Human M-CSF Protein Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Purity＞95%

Table 3. Key Players of Purity≤95%

Table 4. Global Recombinant Human M-CSF Protein Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Recombinant Human M-CSF Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Recombinant Human M-CSF Protein Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Recombinant Human M-CSF Protein Market Share by Region (2020-2025)

Table 8. Global Recombinant Human M-CSF Protein Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Recombinant Human M-CSF Protein Market Share by Region (2026-2031)

Table 10. Recombinant Human M-CSF Protein Market Trends

Table 11. Recombinant Human M-CSF Protein Market Drivers

Table 12. Recombinant Human M-CSF Protein Market Challenges

Table 13. Recombinant Human M-CSF Protein Market Restraints

Table 14. Global Recombinant Human M-CSF Protein Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Recombinant Human M-CSF Protein Market Share by Players (2020-2025)

Table 16. Global Top Recombinant Human M-CSF Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human M-CSF Protein as of 2024)

Table 17. Ranking of Global Top Recombinant Human M-CSF Protein Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Recombinant Human M-CSF Protein Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Recombinant Human M-CSF Protein, Headquarters and Area Served

Table 20. Global Key Players of Recombinant Human M-CSF Protein, Product and Application

Table 21. Global Key Players of Recombinant Human M-CSF Protein, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Recombinant Human M-CSF Protein Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Recombinant Human M-CSF Protein Revenue Market Share by Type (2020-2025)

Table 25. Global Recombinant Human M-CSF Protein Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Recombinant Human M-CSF Protein Revenue Market Share by Type (2026-2031)

Table 27. Global Recombinant Human M-CSF Protein Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Recombinant Human M-CSF Protein Revenue Market Share by Application (2020-2025)

Table 29. Global Recombinant Human M-CSF Protein Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Recombinant Human M-CSF Protein Revenue Market Share by Application (2026-2031)

Table 31. North America Recombinant Human M-CSF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Recombinant Human M-CSF Protein Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Recombinant Human M-CSF Protein Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Recombinant Human M-CSF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Recombinant Human M-CSF Protein Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Recombinant Human M-CSF Protein Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Recombinant Human M-CSF Protein Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Recombinant Human M-CSF Protein Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Recombinant Human M-CSF Protein Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Recombinant Human M-CSF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Recombinant Human M-CSF Protein Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Recombinant Human M-CSF Protein Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Recombinant Human M-CSF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Recombinant Human M-CSF Protein Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Recombinant Human M-CSF Protein Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novartis Company Details

Table 47. Novartis Business Overview

Table 48. Novartis Recombinant Human M-CSF Protein Product

Table 49. Novartis Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 50. Novartis Recent Development

Table 51. Amgen Company Details

Table 52. Amgen Business Overview

Table 53. Amgen Recombinant Human M-CSF Protein Product

Table 54. Amgen Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. Betta Pharmaceuticals Company Details

Table 57. Betta Pharmaceuticals Business Overview

Table 58. Betta Pharmaceuticals Recombinant Human M-CSF Protein Product

Table 59. Betta Pharmaceuticals Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 60. Betta Pharmaceuticals Recent Development

Table 61. Thermo Fisher Scientific Inc. Company Details

Table 62. Thermo Fisher Scientific Inc. Business Overview

Table 63. Thermo Fisher Scientific Inc. Recombinant Human M-CSF Protein Product

Table 64. Thermo Fisher Scientific Inc. Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 65. Thermo Fisher Scientific Inc. Recent Development

Table 66. Eli Lilly and Company Company Details

Table 67. Eli Lilly and Company Business Overview

Table 68. Eli Lilly and Company Recombinant Human M-CSF Protein Product

Table 69. Eli Lilly and Company Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 70. Eli Lilly and Company Recent Development

Table 71. Bio-Techne Company Details

Table 72. Bio-Techne Business Overview

Table 73. Bio-Techne Recombinant Human M-CSF Protein Product

Table 74. Bio-Techne Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 75. Bio-Techne Recent Development

Table 76. Merck Company Details

Table 77. Merck Business Overview

Table 78. Merck Recombinant Human M-CSF Protein Product

Table 79. Merck Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 80. Merck Recent Development

Table 81. Yeasen Company Details

Table 82. Yeasen Business Overview

Table 83. Yeasen Recombinant Human M-CSF Protein Product

Table 84. Yeasen Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 85. Yeasen Recent Development

Table 86. Sino Biological Company Details

Table 87. Sino Biological Business Overview

Table 88. Sino Biological Recombinant Human M-CSF Protein Product

Table 89. Sino Biological Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 90. Sino Biological Recent Development

Table 91. Miltenyi Biotec Company Details

Table 92. Miltenyi Biotec Business Overview

Table 93. Miltenyi Biotec Recombinant Human M-CSF Protein Product

Table 94. Miltenyi Biotec Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 95. Miltenyi Biotec Recent Development

Table 96. Proteintech Company Details

Table 97. Proteintech Business Overview

Table 98. Proteintech Recombinant Human M-CSF Protein Product

Table 99. Proteintech Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 100. Proteintech Recent Development

Table 101. BioLegend Company Details

Table 102. BioLegend Business Overview

Table 103. BioLegend Recombinant Human M-CSF Protein Product

Table 104. BioLegend Revenue in Recombinant Human M-CSF Protein Business (2020-2025) & (US$ Million)

Table 105. BioLegend Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Recombinant Human M-CSF Protein Picture

Figure 2. Global Recombinant Human M-CSF Protein Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Recombinant Human M-CSF Protein Market Share by Type: 2024 VS 2031

Figure 4. Purity＞95% Features

Figure 5. Purity≤95% Features

Figure 6. Global Recombinant Human M-CSF Protein Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Recombinant Human M-CSF Protein Market Share by Application: 2024 VS 2031

Figure 8. Medical and Biological Laboratories Case Studies

Figure 9. University Laboratories Case Studies

Figure 10. Others Case Studies

Figure 11. Recombinant Human M-CSF Protein Report Years Considered

Figure 12. Global Recombinant Human M-CSF Protein Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Recombinant Human M-CSF Protein Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Recombinant Human M-CSF Protein Market Share by Region: 2024 VS 2031

Figure 15. Global Recombinant Human M-CSF Protein Market Share by Players in 2024

Figure 16. Global Recombinant Human M-CSF Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Recombinant Human M-CSF Protein Revenue in 2024

Figure 18. North America Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Recombinant Human M-CSF Protein Market Share by Country (2020-2031)

Figure 20. United States Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Recombinant Human M-CSF Protein Market Share by Country (2020-2031)

Figure 24. Germany Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Recombinant Human M-CSF Protein Market Share by Region (2020-2031)

Figure 32. China Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Recombinant Human M-CSF Protein Market Share by Country (2020-2031)

Figure 40. Mexico Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Recombinant Human M-CSF Protein Market Share by Country (2020-2031)

Figure 44. Turkey Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Recombinant Human M-CSF Protein Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Novartis Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 48. Amgen Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 49. Betta Pharmaceuticals Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 51. Eli Lilly and Company Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 52. Bio-Techne Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 54. Yeasen Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 55. Sino Biological Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 56. Miltenyi Biotec Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 57. Proteintech Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 58. BioLegend Revenue Growth Rate in Recombinant Human M-CSF Protein Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030

Global Recombinant Human GM CSF for Injection Market Research Report 2024

Global Stem Cell Factor SCF Market Research Report 2024

Global Granulocyte Colony stimulating Factor G CSF ELISA Kit Market Research Report 2024

Global Cell Therapy Growth Factors Market Research Report 2024

Global Human Leukemia Inhibitory Factor Recombinant Protein Market Research Report 2024

Global Human Recombinant LIF Market Research Report 2024

Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024

Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2024

Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024

Global Granulocyte Macrophage Colony Stimulating Factor GM CSF ELISA Kit Market Research Report 2024

Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024

Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024

Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2025

Global Hematopoietic Stem Cells Storage and Consumables Market Research Report 2025

Global Recombinant Cytokines Drug Market Insights Forecast to 2030

Global Pegfilgrastim Market Insights Forecast to 2030

Transplantation of Multipotent Hematopoietic Stem Cells Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions